Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis

被引:35
作者
Defourny, Noemie [1 ]
Dunscombe, Peter [2 ]
Perrier, Lionel [3 ]
Grau, Cai [4 ]
Lievens, Yolande [5 ]
机构
[1] European Soc Radiotherapy & Oncol, Brussels, Belgium
[2] Univ Calgary, Calgary, AB, Canada
[3] Ctr Reg Lutte Canc Leon Berard, Lyon, France
[4] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[5] Ghent Univ Hosp, Dept Radiat Oncol, Ghent, Belgium
关键词
Systematic review; Cost evaluation; Cost assessment; Radiotherapy; External beam; Photon beam; PAINFUL BONE METASTASES; RADIATION ONCOLOGY; EUROPEAN COUNTRIES; GAMMA-KNIFE; MINIMIZATION ANALYSIS; HEALTH ECONOMICS; UTILITY ANALYSIS; CANCER; THERAPY; HEAD;
D O I
10.1016/j.radonc.2016.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although economic evidence is becoming mandatory to support health care decision-making, challenges remain in generating high quality cost data, especially for complex and rapidly evolving treatment modalities, such as radiotherapy. The overall aim of this systematic literature review was to critically analyse the type and quality of radiotherapy cost information available in cost calculation studies, from the health care provider's perspective, published since 1981. A selection process, based on strict and explicit criteria, yielded 52 articles. In spite of meeting our criteria these studies displayed large heterogeneity in scope, costing method, inputs and outputs. The limited use of conventional costing methodologies along with insufficient information on resource inputs hampered comparability across studies. A consistent picture of radiotherapy costs, based on methodologically sound costing studies, has yet to emerge. These results call for developing a well-defined and generally accepted cost methodology for performing economic evaluation studies in radiotherapy. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:468 / 474
页数:7
相关论文
共 72 条
[1]   Expanding global access to radiotherapy [J].
Atun, Rifat ;
Jaffray, David A. ;
Barton, Michael B. ;
Bray, Freddie ;
Baumann, Michael ;
Vikram, Bhadrasain ;
Hanna, Timothy P. ;
Knaul, Felicia M. ;
Lievens, Yolande ;
Lui, Tracey Y. M. ;
Milosevic, Michael ;
O'Sullivan, Brian ;
Rodin, Danielle L. ;
Rosenblatt, Eduardo ;
Van Dyk, Jacob ;
Yap, Mei Ling ;
Zubizarreta, Eduardo ;
Gospodarowicz, Mary .
LANCET ONCOLOGY, 2015, 16 (10) :1153-1186
[2]   What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer [J].
Barbieri M. ;
Weatherly H.L.A. ;
Ara R. ;
Basarir H. ;
Sculpher M. ;
Adams R. ;
Ahmed H. ;
Coles C. ;
Guerrero-Urbano T. ;
Nutting C. ;
Powell M. .
Applied Health Economics and Health Policy, 2014, 12 (5) :497-510
[3]   An Improved Set of Standards for Finding Cost for Cost-Effectiveness Analysis [J].
Barnett, Paul G. .
MEDICAL CARE, 2009, 47 (07) :S82-S88
[4]   Treatment with gamma knife versus stereotactic linear accelerator. Clinical results and the cost-effectiveness [J].
Becker, G ;
Kortmann, R ;
Kaulich, TW ;
Duffner, F ;
Bamberg, M .
RADIOLOGE, 1996, 36 (04) :345-353
[5]  
Best J, 1993, Qual Assur Health Care, V5, P219
[6]   The cost of intensity modulated radiation therapy in head and neck cancers:: results of the 2002 STIC study [J].
Bonastre, M. Julia ;
Noel, ErIc ;
Bensadoun, Rene-Jean ;
Chapet, Olivier ;
Favrel, Veronique ;
Dubois, Jean-Bernard ;
Ailleres, Norbert ;
Giraud, Philippe ;
Lefkopoulos, Dimitri ;
Marcie, Serge ;
Lagarde, Philippe ;
Gardner, Miriam ;
Rives, Michel ;
Mailleux, Hugues ;
Bourhis, Jean ;
Gerard, Jean-Pierre ;
de Pouvourville, Gerard .
BULLETIN DU CANCER, 2006, 93 (10) :1026-1032
[7]   How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis [J].
Borras, Josep M. ;
Lievens, Yolande ;
Barton, Michael ;
Corral, Julieta ;
Ferlay, Jacques ;
Bray, Freddie ;
Grau, Cai .
RADIOTHERAPY AND ONCOLOGY, 2016, 119 (01) :5-11
[8]   The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis [J].
Borras, Josep M. ;
Lievens, Yolande ;
Dunscombe, Peter ;
Coffey, Mary ;
Malicki, Julian ;
Corral, Julieta ;
Gasparotto, Chiara ;
Defourny, Noemie ;
Barton, Michael ;
Verhoeven, Rob ;
van Eycken, Liesbeth ;
Primic-Zakelj, Maja ;
Trojanowski, Maciej ;
Strojan, Primoz ;
Grau, Cai ;
Kokobobo, Arianit ;
Sedlmayer, Felix ;
De Hertogh, Olivier ;
Hadjieva, Tatiana ;
Petera, Jiri ;
Eriksen, Jesper Grau ;
Jaal, Jana ;
Azria, David ;
Takacsi-Nagy, Zoltan ;
Johannsson, Jakob ;
Cunningham, Moya ;
Atkocius, Vydmantas ;
Untereiner, Michel ;
Pirotta, Martin ;
Karadjinovic, Vanja ;
Levernes, Sverre ;
Skladowski, Krystof ;
Trigo, Maria Lurdes ;
Segedin, Barbara ;
Cabezas, Sonia Garcia ;
Lagerlund, Magnus ;
Pastoors, Bert ;
Slotman, Ben ;
Beardmore, Charlotte ;
Smyth, Gaile ;
Vaarkamp, Jaap ;
Dyzmann-Sroka, Agnieszka ;
Kubiak, Anna ;
Henau, Kris ;
Lemmens, Valery .
RADIOTHERAPY AND ONCOLOGY, 2015, 116 (01) :38-44
[9]   Costs of treatment intensification for head and neck cancer: Concomitant chemoradiation randomised for radioprotection with amifostine [J].
Braaksma, M ;
van Agthoven, M ;
Nijdam, W ;
Uyl-de Groot, C ;
Levendag, P .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) :2102-2111
[10]  
COY P, 1994, CLIN INVEST MED, V17, P577